IP Verse

Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. vs Gilead Pharmasset LLC

The detailed information for PTAB case with proceeding number IPR2018-00211 filed by Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. against Gilead Pharmasset LLC on Dec 6, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2018-00211
Filing Date
Dec 6, 2017
Petitioner
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al.
Respondent
Gilead Pharmasset LLC
Status
Institution Denied
Respondent Application Number
13875252
Respondent Tech Center
1600
Respondent Patent Number
9393256
Institution Decision Date
Jun 20, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Aug 8, 2018PAPERBOARD

Petitioner's Requests for Refund of Post-Institution Fees

Jul 21, 2018PAPERPETITIONER

Decision Denying Institution of Inter Partes Review

Jun 20, 2018PAPERBOARD

File Wrapper for U.S. Patent No. 9,393,256

Apr 10, 2018EXHIBITPATENT OWNER

Patent Owner's Preliminary Response

Apr 10, 2018PAPERPATENT OWNER

Bert M. Klebl et al., Host Cell Targets in HCV Therapy Novel Strategy or Proven Practice

Apr 10, 2018EXHIBITPATENT OWNER

Jacqueline G. OLeary & Gary L. Davis, Hepatitis C Virus Replication and Potential Targets

Apr 10, 2018EXHIBITPATENT OWNER

America¿¿¿s Overspend How the Pharmaceutical Patent Problem Is Fueling

Apr 10, 2018EXHIBITPATENT OWNER

David. L. Wyles et al., Synergy of Small Molecular Inhibitors of Hepatitis C Virus

Apr 10, 2018EXHIBITPATENT OWNER

Press Release, Gilead Sciences, Inc., U.S. Food and Drug Administration

Apr 10, 2018EXHIBITPATENT OWNER

Our People, I-MAK (2018)

Apr 10, 2018EXHIBITPATENT OWNER

Eric Lawitz et al., Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection

Apr 10, 2018EXHIBITPATENT OWNER

Notice of Accord Filing Date

Jan 10, 2018PAPERBOARD

Patent Owners Mandatory Notices

Dec 22, 2017PAPERPATENT OWNER

Gilead Pharmasset Power of Attorney

Dec 22, 2017PAPERPATENT OWNER

Clark

Dec 6, 2017EXHIBITPETITIONER

Ma

Dec 6, 2017EXHIBITPETITIONER

Legrand-Abravanel

Dec 6, 2017EXHIBITPETITIONER

Sofia 2007

Dec 6, 2017EXHIBITPETITIONER

Pockros

Dec 6, 2017EXHIBITPETITIONER

Power of Attorney

Dec 6, 2017PAPERPETITIONER

Petition for Inter Partes Review

Dec 6, 2017PAPERPETITIONER

U.S Patent No. 9,393,256

Dec 6, 2017EXHIBITPETITIONER

Sofia 634

Dec 6, 2017EXHIBITPETITIONER

Serrano-Wu

Dec 6, 2017EXHIBITPETITIONER

Simmen

Dec 6, 2017EXHIBITPETITIONER

Delaney

Dec 6, 2017EXHIBITPETITIONER

Guo (pages 1-600)

Dec 6, 2017EXHIBITPETITIONER

Declaration of Joseph M. Fortunak, Ph.D.

Dec 6, 2017EXHIBITPETITIONER

Guo (pages 1-600)

Dec 6, 2017EXHIBITPETITIONER

Guo (pages 601-1092)

Dec 6, 2017EXHIBITPETITIONER